We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ALZN market cap is 4.77M. The company's latest EPS is USD -2.0894 and P/E is -0.32.
| Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.11M | -5.42M | -3.3M | -3.53M | -2.9M |
| Net Income | -3.11M | -5.43M | -3.31M | -3.53M | -2.91M |
| Year End 30 April 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -3.17M | -4.95M | -12.32M | -14.87M |
| Net Income | -3.17M | -5.05M | -12.36M | -14.88M |
| Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 10.43M | 8.5M | 5.92M | 2.63M | 984k |
| Total Liabilities | 1.64M | 2.64M | 2.87M | 2.74M | 3.67M |
| Total Equity | 8.79M | 5.86M | 3.05M | -113k | -2.68M |
| Year End 30 April 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.81M | 2.91M | 14.52M | 5.92M |
| Total Liabilities | 992k | 899k | 1.17M | 2.87M |
| Total Equity | 822k | 2.01M | 13.35M | 3.05M |
| Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -4.88M | -6.69M | -8.92M | -3.3M | -4.81M |
| Investing | N/A | N/A | N/A | -147k | -147k |
| Financing | N/A | N/A | N/A | N/A | 18k |
| Year End 30 April 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.15M | -2.71M | -6.61M | -8.92M |
| Investing | 105k | 101k | -106k | N/A |
| Financing | 2.29M | 4.45M | 18.85M | N/A |
| Market Cap | 4.77M |
| Price to Earnings Ratio | -0.32 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.93 |
| Price to Book Ratio | 1.57 |
| Dividend Yield | - |
| Shares Outstanding | 7.12M |
| Average Volume (1 week) | 55.73k |
| Average Volume (1 Month) | 50.16k |
| 52 Week Change | -91.95% |
| 52 Week High | 11.91 |
| 52 Week Low | 0.6516 |
| Spread (Intraday) | 0.02 (2.88%) |
| Company Name | Alzamend Neuro Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.alzamend.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
